Related Experiment Videos
Apoptosis in breast carcinoma.
R González-Cámpora1, M R Galera Ruiz, F Vázquez Ramírez
1Department of Pathology, Hospital Universitario Virgen Macarena, Faculty of Medicine, Seville, Spain.
Pathology, Research and Practice
|March 24, 2000
Summary
Apoptosis, programmed cell death, is a key factor in breast cancer survival. Higher apoptosis rates independently predict better survival, regardless of proliferation or specific protein markers like bcl-2 and p53.
Area of Science:
- Oncology
- Cell Biology
- Pathology
Background:
- Apoptosis (programmed cell death) is implicated in tumor growth and aggressiveness.
- Understanding its role alongside protein expression and proliferation is crucial for breast cancer prognosis.
Purpose of the Study:
- To investigate the relationship between apoptosis, bcl-2 and p53 protein expression, proliferation index, and clinicopathological features in breast carcinoma.
- To determine the prognostic significance of apoptosis in breast cancer survival.
Main Methods:
- Analyzed 65 invasive ductal breast carcinoma tissue sections.
- Quantified apoptosis using the TUNEL assay.
- Assessed expression of estrogen receptor, Ki67, bcl-2, and p53 via immunohistochemistry.
Main Results:
- Apoptotic cell counts varied significantly, with higher counts associated with higher histological grade.
- Grade I tumors showed low apoptosis and high bcl-2 expression, while Grade III tumors exhibited high apoptosis and p53 expression.
- Multivariate analysis identified estrogen receptor status and apoptosis as independent prognostic variables for survival.
Conclusions:
- Apoptosis is a significant independent prognostic factor for survival in breast cancer patients.
- Apoptosis appears more critical for prognosis than proliferation index or bcl-2/p53 protein expression.